Global Biomarkers Market, By Type (Safety, Efficacy, Validation), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Product Type (Consumables, Services, Software), Technology (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The biomarkers market is expected to witness market growth at a rate of 14.5% in the forecast period of 2021 to 2028 and is expected to reach USD 133.46 billion by 2028. Data Bridge Market Research report on biomarkers market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increasing diagnostic applications of biomarkers across the globe are escalating the growth of biomarkers market.
Biomarkers which are also called molecular marker or signature molecule are utilized to check that how body responds to a treatment of any condition or disease. They assist in examining the organ functions and other health conditions. These play an important role in the imaging technology so that they can provide clear imaging of oncology tumors and other problems. They are extensively utilized in the clinical studies for the determination of the effect and results of drugs in early stage.
The increasing number of research and technological advancement activities for the development of biomarker-based clinical diagnostics and the rise in the prevalence of chronic diseases such as cancer, diabetes, cardiovascular disorders due to sedentary lifestyle, unhealthy diet and lack of exercise are the major factors driving the biomarkers market. The growing rate of contract research organizations (CROs) and the use of biomarkers for the treatment of several neurological diseases by tracking brain health and activity by analyzing biomolecules accelerate the biomarkers market growth. Nascent developments including biomarker signatures lead the treatment rate of neurological diseases resulting in early diagnosis, non-invasive testing and rapid drug development which also influence the biomarkers market. Additionally, government initiatives intended to reduce healthcare expenses through personalized medicines, increasing research and development funding for pharma and biotech companies and new initiatives for biomarker research positively affect the biomarkers market. Furthermore, technological advancements have enabled the combination of biomarkers with novel drugs for precise diagnosis and advanced treatment options extend profitable opportunities to the biomarkers market players in the forecast period of 2021 to 2028.
On the other hand, high capital investments and low cost-benefit ratio and poorly suited regulatory and reimbursement systems are the factors expected to obstruct the biomarkers market growth. Technical issues related to sample collection and storage, and proving the clinical validity in biomarker-based tests are projected to challenge the biomarkers market in the forecast period of 2021 to 2028.
This biomarkers market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biomarkers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Biomarkers Market Scope and Market Size
The biomarkers market is segmented on the basis of type, application, product type, technology and indication. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the biomarkers market is segmented into safety, efficacy and validation.
- On the basis of application, the biomarkers market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease-risk assessment and others.
- On the basis of product type, the biomarkers market is segmented into consumables, services and software.
- On the basis of technology, the biomarkers market is segmented into safety biomarkers, efficacy biomarkers and validation biomarkers.
- On the basis of indication, the biomarkers market is segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders and others.
Global Biomarkers Market Country Level Analysis
The biomarkers market is analyzed and market size insights and trends are provided by country type, application, product type, technology and indication as referenced above.
The countries covered in the biomarkers market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biomarkers market because of the rising disease burden, regional presence of regulatory bodies along with key players and proactive government initiatives. Asia-Pacific is expected to witness significant growth in CAGR during the forecast period of 2021-2028 because of the presence of prominent players, increasing research and development investment in the developing countries, economic growth and strategic initiatives for co-development of products among players.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The biomarkers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biomarkers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biomarkers market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Biomarkers Market Share Analysis
The biomarkers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to biomarkers market.
The major players covered in the biomarkers market report are Enzo Biochem Inc., Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer Inc., QIAGEN, Agilent Technologies, Inc., Bruker, Epigenomics AG, MESO SCALE DIAGNOSTICS, LLC, EKF Diagnostics Holdings plc, General Electric Company, Nexus-Dx, LifeSign LLC, F. Hoffmann-La Roche Ltd among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Biomarkers Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.